Journal metric profile

Current Stem Cell Research & Therapy

Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor, five-year Impact Factor, quartile, category rank, publisher, identifiers and citation profile for the 2025 metric year.

JCR-based Impact Factor 2.200 2025 metric year
5-Year Impact Factor 2.500 Longer citation window
JCR Quartile Q4 Subject-category quartile
JCR Category Rank 158/204 Recorded category rank

Current Stem Cell Research & Therapy JCR impact factor overview

This profile summarizes the journal metrics and publication information available in the current directory record.

Page reviewed August 6, 2026

Current Stem Cell Research & Therapy metric snapshot

Current Stem Cell Research & Therapy has a bibliometric profile in this directory for 2025. The publisher recorded for the journal is BENTHAM SCIENCE PUBL LTD. Its listed Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor is 2.200. The five-year Journal Impact Factor is 2.500, giving a second citation window for comparison. The journal is recorded in quartile Q4 for its listed JCR category.

Category position and quartile

The recorded JCR category position is 158 out of 204 journals. Based on that rank position, the journal sits within approximately the top 77% of the listed category. Its listed quartile is Q4. Category ranks and quartiles are field-specific and are not measures of the quality of an individual article.

How the citation indicators compare

The five-year Journal Impact Factor (2.500) is 0.300 points higher than the standard Journal Impact Factor (2.200). Without journal self-citations, the Impact Factor is 2.000, a difference of 0.200 points from the listed standard value. The Journal Citation Indicator (JCI) is recorded as 0.350. These measures use different definitions or citation windows, so they are most useful when read together rather than treated as interchangeable scores.

Citation and publication counts

For 2025, the directory record for Current Stem Cell Research & Therapy lists total cites: 1,988; total articles: 86; citable items: 176. These fields describe different parts of the JCR record and should not be combined into an article-level quality score.

Citation half-life profile

The cited half-life is 5.5 years, indicating the median age of items that contributed citations to the journal in the reporting framework. The citing half-life is 7.4 years, indicating the median age of references used by the journal’s articles.

Identifiers and verification

Current Stem Cell Research & Therapy is identified in this directory by print ISSN 1574-888X and electronic ISSN 2212-3946. The publisher is recorded as BENTHAM SCIENCE PUBL LTD. When making submission, library, or research-evaluation decisions, verify the title and identifiers against the journal publisher and the official Clarivate Journal Citation Reports record.

Complete journal information

Use this table to verify the individual metric values, identifiers and publication details stored for this journal.

Journal nameCurrent Stem Cell Research & Therapy
Abbreviated journalCURR STEM CELL RES T
PublisherBENTHAM SCIENCE PUBL LTD
Metric year2025
Overall rank7,420
ISSN1574-888X
eISSN2212-3946
Total cites1,988
Total articles86
Citable items176
Cited half-life5.5 years
Citing half-life7.4 years
JCR-based Journal Impact Factor2.200
5-Year Impact Factor2.500
Impact Factor without journal self-cites2.000
Journal Citation Indicator0.350
JCR Impact Factor quartileQ4
JCR category rank158/204
Database record updated

Frequently asked questions

What is the 2025 JCR-based Journal Impact Factor of Current Stem Cell Research & Therapy?

The Journal Impact Factor recorded in this directory as a Clarivate Journal Citation Reports (JCR)-based value for Current Stem Cell Research & Therapy is 2.200 for the 2025 metric year.

What are the JCR quartile and category rank of Current Stem Cell Research & Therapy?

Current Stem Cell Research & Therapy is listed with quartile Q4 and category rank 158/204. These values are category-specific and should be verified against the official JCR record when used for formal assessment.

What is the five-year Journal Impact Factor of Current Stem Cell Research & Therapy?

The five-year Journal Impact Factor recorded for Current Stem Cell Research & Therapy is 2.500. It uses a longer citation window than the standard Journal Impact Factor.

Who publishes Current Stem Cell Research & Therapy?

Current Stem Cell Research & Therapy is listed in this directory as being published by BENTHAM SCIENCE PUBL LTD.

Additional records from the same publisher or with a similar listed JCR Impact Factor.